McCartney Matthew, Phagura Ravinder Singh
Hobart Eye Surgeons, Hobart, Tasmania, Australia.
Am J Ophthalmol Case Rep. 2020 Mar 4;18:100635. doi: 10.1016/j.ajoc.2020.100635. eCollection 2020 Jun.
Microinvasive glaucoma surgery and its associated devices remain a field of continued interest and innovation in the management of patients with glaucoma. While a range of outflow optimisation devices have been designed, the efficacy and safety and these devices remains to be proven, particularly in the long term.
The authors present the first reported case to our knowledge of bilateral hypertensive crisis associated with CyPass® Micro-stent insertion two months post-operation and its resultant management.
Despite the recall of the CyPass Micro-stent (Alcon, Fort Worth, Texas, USA), further clinical experience in the use of these and similar stents is required. Possible hypotheses explaining this phenomenon are also presented, the most likely being sudden closure of the suprachoroidal space.
微创青光眼手术及其相关设备在青光眼患者的治疗中仍是一个持续受到关注和创新的领域。虽然已经设计了一系列流出优化设备，但这些设备的疗效和安全性仍有待证实，尤其是长期效果。
据作者所知，本文首次报告了1例与CyPass®微支架植入术后2个月相关的双侧高血压危象病例及其处理情况。
尽管CyPass微支架（爱尔康公司，美国得克萨斯州沃思堡）已被召回，但仍需要对这些及类似支架的使用进行更多临床经验积累。本文还提出了解释这一现象的可能假说，最有可能的是脉络膜上腔突然闭合。
